As of May 27, 2025, CVS Health Corp (CVS) reports a EV/EBITDA of 12.87.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing CVS Health Corp's EV/EBITDA to Peers
To better understand CVS Health Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| CVS Health Corp (CVS) | 12.87 |
| AMN Healthcare Services Inc (AMN) | 44.45 |
| CorVel Corp (CRVL) | 39.69 |
| LHC Group Inc (LHCG) | 39.66 |
| R1 RCM Inc (RCM) | 19.37 |
| Amedisys Inc (AMED) | 17.91 |
Compared to its competitors, CVS Health Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.